Recombinant gland related virus expressing human kallikrein, its preparation method and application
A kallikrein and adenovirus technology, applied in virus/phage, recombinant DNA technology, medical preparations containing active ingredients, etc., can solve the problems of complex replication and transcription regulation of adeno-associated virus
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] Cloning of human kallikrein (HK) cDNA and its recombination and construction with rAAV.
[0035] 1) Cloning of human kallikrein (HK) cDNA
[0036] Design primers: P1, 5'-GCAGAATTCATGTGGTTCCTGG-3'; P2, 5'-GACAAGCTTTTACTGGGGGTA-3'. Synthesized by Wuhan Biosynthesis Company. Total RNA was extracted from human liver specimens with a TRIZOL kit (purchased from GIBCO), and subjected to RT-PCR (the kit was purchased from TAKARA, Japan). The PCR instrument was purchased from TECONE, UK. and the product with pXXUF 1 connected. HKcDNA pXXUF 1 replaced by the gfp gene in pXXUF 1 Plasmid composition of -HK, as attached Figure 7 shown.
[0037] The HKcDNA was sequenced, and the results obtained were the same as those from GeneBank. But according to the principle of Kozak sequence: First, the first ATG downstream of the promoter is often used as a translation initiation codon, followed by the 3 positions adjacent to ATG are usually A / G, and the +4 position is G, any 3 or +4...
Embodiment 2
[0053] Antihypertensive Effect of rAAV-HK on Spontaneously Hypertensive Rat (SHR) Model
[0054] The spontaneously hypertensive rat model was purchased from the Shanghai Institute of Hypertension. A total of 12 rats were divided into two groups, and rAAV-HK and rAAV-LacZ viruses were injected through the tail vein respectively, and the amount used for each rat was 1×10 11 p.f.u. Blood pressure was measured weekly after injection, and 24-hour urine was collected every half month. It was found that the blood pressure of the rats in the experimental group began to drop 3-4 weeks after the injection, and all the animals were killed after five months. The results are shown in Figure 9 .
Embodiment 3
[0056] The role of rAAV-HK in preventing stroke
[0057] 8-16 weeks after gene injection, 2 out of 6 animals in the control group (rAAV-lacZ group) had stroke (confirmed by autopsy), one of which was cerebral hemorrhage and the other was multiple cerebral infarction. In the experimental group, none had stroke.
PUM

Abstract
Description
Claims
Application Information

- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com